{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:09:37Z","timestamp":1786975777877,"version":"build-2736575974"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"\n Importance<\/jats:title>\n Claudication is associated with walking impairment, but amputation risk is generally low unless symptoms progress to chronic limb-threatening ischemia (CLTI). Disparities in amputation risk have been described previously, but population-specific rates of revascularization for claudication, postrevascularization progression from claudication to CLTI, and rates of guideline-based risk-reduction pharmacotherapy are unknown.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To explore the impact of intersectional identity among a cohort of patients with claudication on progression to CLTI, amputation, and mortality following revascularization.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This national cohort study was conducted using the Vascular Quality Initiative (VQI) procedural registry, which was linked to the Medicare dataset of patients who underwent index revascularization for claudication from January 1, 2016, to December 31, 2019. Patients with claudication undergoing an index lower-extremity revascularization procedure (aortoiliac and infrainguinal arterial occlusive disease) at VQI-participating centers were eligible for inclusion. Data analysis was conducted from December 2024 to February 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n The primary exposure was an intersectional variable combining race, ethnicity, and sex.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n The primary outcome was development of CLTI within 180 days after index revascularization (defined by a validated CLTI-specific\n International Statistical Classification of Diseases and Related Health Problems, Tenth Revision [ICD-10]<\/jats:italic>\n code). Secondary outcomes included major amputation and mortality. Survival analyses were used to examine outcomes.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 10\u202f012 patients undergoing revascularization for claudication (median [IQR] age, 71 [66-76] years; 3850 female patients [38.5%]), self-identified intersectional identity distribution was 151 (1.5%) Hispanic men, 92 (0.9%) Hispanic women, 502 (5.0%) non-Hispanic Black men, 422 (4.2%) non-Hispanic Black women, 5509 (55.0%) non-Hispanic White men, and 3336 (33.3%) non-Hispanic White women. Black and Hispanic patients with claudication were more likely to have diabetes and be undergoing dialysis. Black men had the highest prevalence of active smokers (38.6%) while Hispanic women were more often never smokers (30.4%). A higher proportion of White men (80.9%) were receiving preoperative statin therapy compared to all other groups. The highest rates of postrevascularization progression to CLTI within 180 days were observed among Black women (11.8%; Hispanic: 3.8%; White: 5.9%), followed by Hispanic men (8.8%; Black: 7.2%; White: 5.2%). Major amputation rates were also highest among Black patients (180 days: Black women, 0.8%; Black men, 0.7%).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n According to the results of this cohort study, Black women had the highest rate of postrevascularization progression from claudication to CLTI. Development of practice- and policy-level standards incentivizing evidence-based claudication management may support equitable outcomes and reduce disparities.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamasurg.2025.5556","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T17:30:32Z","timestamp":1765992632000},"page":"161","source":"Crossref","is-referenced-by-count":3,"title":["Progression to Chronic Limb-Threatening Ischemia After Index Revascularization for Claudication"],"prefix":"10.1001","volume":"161","author":[{"given":"Olamide","family":"Alabi","sequence":"first","affiliation":[{"name":"Surgical and Perioperative Care, Atlanta VA Health Care System, Decatur, Georgia"},{"name":"Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae","family":"Rokosh","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin W.","family":"Hicks","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Spangler","sequence":"additional","affiliation":[{"name":"Birmingham VA Health Care System, Birmingham, Alabama"},{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Velazquez","sequence":"additional","affiliation":[{"name":"Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakra","family":"Hughes","sequence":"additional","affiliation":[{"name":"Howard University College of Medicine, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Goodney","sequence":"additional","affiliation":[{"name":"Geisel School of Medicine at Dartmouth, Hanover, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"George","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipra","family":"Arya","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Corriere","sequence":"additional","affiliation":[{"name":"The Ohio State University College of Medicine, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"soi250085r1","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association.","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"soi250085r2","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jvs.2007.02.004","article-title":"A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences.","volume":"45","author":"Sigvant","year":"2007","journal-title":"J Vasc Surg"},{"key":"soi250085r3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2147\/VHRM.S209241","article-title":"The burden of critical limb ischemia: a review of recent literature.","volume":"15","author":"Duff","year":"2019","journal-title":"Vasc Health Risk Manag"},{"issue":"9901","key":"soi250085r4","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"issue":"12","key":"soi250085r5","doi-asserted-by":"publisher","first-page":"e686","DOI":"10.1161\/CIR.0000000000000470","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"issue":"21","key":"soi250085r6","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.jacc.2012.08.983","article-title":"Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000-2008.","volume":"60","author":"Jones","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"soi250085r7","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jvs.2022.10.025","article-title":"Early peripheral vascular interventions for claudication are associated with higher rates of late interventions and progression to chronic limb threatening ischemia.","volume":"77","author":"Sorber","year":"2023","journal-title":"J Vasc Surg"},{"issue":"3","key":"soi250085r8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ejvs.2015.10.022","article-title":"The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease.","volume":"51","author":"Sigvant","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"10","key":"soi250085r9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.120.009326","article-title":"Association of disease progression with cardiovascular and limb outcomes in patients with peripheral artery disease: insights from the EUCLID trial.","volume":"13","author":"Rymer","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"soi250085r10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jvs.2021.02.045","article-title":"Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation rates.","volume":"74","author":"Madabhushi","year":"2021","journal-title":"J Vasc Surg"},{"key":"soi250085r11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.avsg.2020.10.004","article-title":"Multiple reinterventions for claudication are associated with progression to chronic limb-threatening ischemia.","volume":"72","author":"Kim","year":"2021","journal-title":"Ann Vasc Surg"},{"issue":"24","key":"soi250085r12","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/j.jacc.2023.09.830","article-title":"Disparities in diagnosis, treatment, and outcomes of peripheral artery disease: JACC scientific statement.","volume":"82","author":"McDermott","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"soi250085r14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jvs.2022.01.132","article-title":"Validation of an indirect linkage algorithm to combine registry data with Medicare claims.","volume":"76","author":"Mao","year":"2022","journal-title":"J Vasc Surg"},{"issue":"6","key":"soi250085r15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","article-title":"STROBE Reporting Guidelines for Observational Studies.","volume":"156","author":"Ghaferi","year":"2021","journal-title":"JAMA Surg"},{"issue":"7","key":"soi250085r16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.124.011467","article-title":"Validation of ICD-10 codes to distinguish between claudication and chronic limb-threatening ischemia in patients undergoing peripheral vascular intervention using Medicare-matched registry data.","volume":"18","author":"Bose","year":"2025","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"soi250085r17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/archsurg.1974.01360050087019","article-title":"Intermittent claudication. surgical significance.","volume":"109","author":"Peabody","year":"1974","journal-title":"Arch Surg"},{"issue":"5","key":"soi250085r18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0002-9610(76)90351-2","article-title":"The fate of patients with intermittent claudication managed nonoperatively.","volume":"132","author":"McAllister","year":"1976","journal-title":"Am J Surg"},{"issue":"5","key":"soi250085r19","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jamcollsurg.2007.12.033","article-title":"Do current outcomes justify more liberal use of revascularization for vasculogenic claudication? a single center experience of 1,000 consecutively treated limbs.","volume":"206","author":"Taylor","year":"2008","journal-title":"J Am Coll Surg"},{"key":"soi250085r20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.avsg.2024.12.009","article-title":"Rate and predictors of disease progression in patients with conservatively managed intermittent claudication: a systematic review.","volume":"112","author":"Froud","year":"2025","journal-title":"Ann Vasc Surg"},{"issue":"14","key":"soi250085r21","doi-asserted-by":"publisher","first-page":"e877","DOI":"10.1161\/CIR.0000000000001310","article-title":"Sex differences in peripheral vascular disease: a scientific statement from the American Heart Association.","volume":"151","author":"Kim","year":"2025","journal-title":"Circulation"},{"issue":"4","key":"soi250085r22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.amepre.2006.12.010","article-title":"Ethnic-specific prevalence of peripheral arterial disease in the United States.","volume":"32","author":"Allison","year":"2007","journal-title":"Am J Prev Med"},{"issue":"3","key":"soi250085r23","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jvs.2017.06.111","article-title":"Controversies and evidence for cardiovascular disease in the diverse Hispanic population.","volume":"67","author":"Shaw","year":"2018","journal-title":"J Vasc Surg"},{"key":"soi250085r24","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.692236","article-title":"Disparities in peripheral artery disease hospitalizations identified among understudied race-ethnicity groups.","volume":"8","author":"Chen","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"soi250085r25","first-page":"22","article-title":"Racial and geographic variation in leg amputations among Texans.","volume":"70","author":"Barshes","year":"2018","journal-title":"Tex Public Health J"},{"issue":"17","key":"soi250085r26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013088","article-title":"Role of sex in determining treatment type for patients undergoing endovascular lower extremity revascularization.","volume":"8","author":"Ramkumar","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"soi250085r27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/ccd.30617","article-title":"Association between sex and long-term outcomes of endovascular treatment for peripheral artery disease.","volume":"101","author":"Ramkumar","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"soi250085r28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.tcm.2020.06.005","article-title":"Premature atherosclerotic peripheral artery disease: An underrecognized and undertreated disorder with a rising global prevalence.","volume":"31","author":"Mehta","year":"2021","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"soi250085r29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jvs.2019.10.075","article-title":"Race and socioeconomic differences associated with endovascular peripheral vascular interventions for newly diagnosed claudication.","volume":"72","author":"Hicks","year":"2020","journal-title":"J Vasc Surg"},{"issue":"2","key":"soi250085r30","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jvs.2022.08.033","article-title":"Practice patterns surrounding the use of tibial interventions for claudication in the Medicare population.","volume":"77","author":"Bose","year":"2023","journal-title":"J Vasc Surg"},{"issue":"14","key":"soi250085r31","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033463","article-title":"Trends and factors associated with peripheral vascular interventions for the treatment of claudication from 2011 to 2022: a national Medicare cohort study.","volume":"13","author":"Dun","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"soi250085r32","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006368","article-title":"Infrapopliteal endovascular interventions for claudication are associated with poor long-term outcomes in Medicare-matched registry patients.","author":"Bose","year":"2024","journal-title":"Ann Surg"},{"issue":"5","key":"soi250085r33","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.jvs.2024.06.006","article-title":"Practice patterns of peripheral vascular interventions for peripheral artery disease in the office-based laboratory setting versus outpatient hospital.","volume":"80","author":"Tsou","year":"2024","journal-title":"J Vasc Surg"},{"issue":"1","key":"soi250085r34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jvs.2022.04.012","article-title":"Society for Vascular Surgery appropriate use criteria for management of intermittent claudication.","volume":"76","author":"Woo","year":"2022","journal-title":"J Vasc Surg"},{"issue":"5","key":"soi250085r35","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.jvs.2020.10.067","article-title":"Endovascular interventions for claudication do not meet minimum standards for the Society for Vascular Surgery efficacy guidelines.","volume":"73","author":"Bath","year":"2021","journal-title":"J Vasc Surg"},{"key":"soi250085r13","unstructured":"The Vascular Quality Initiative. Accessed January 12, 2022. https:\/\/www.vascularqualityinitiative.org\/"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2843042\/jamasurgery_alabi_2025_oi_250085_1770066738.83456.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:00:35Z","timestamp":1770825635000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2843042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2025.5556","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,1]]}}}